TrianglePUBLICATIONS · 28478340
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2017 Jul
- First author
- Lebellec L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Lebellec L
- type
- Author
- name
- Chauffert B
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Chevreau C
- type
- Author
- name
- Bompas E
- type
- Author
- name
- Bertucci F
- type
- Author
- name
- Cupissol D
- type
- Author
- name
- Fabbro M
- type
- Author
- name
- Saada-Bouzid E
- type
- Author
- name
- Duffaud F
- type
- Author
- name
- Feuvret L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lebellec L
- type
- Author
- name
- Chauffert B
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Chevreau C
- type
- Author
- name
- Bompas E
- type
- Author
- name
- Bertucci F
- type
- Author
- name
- Cupissol D
- type
- Author
- name
- Fabbro M
- type
- Author
- name
- Saada-Bouzid E
- type
- Author
- name
- Duffaud F
- type
- Author
- name
- Feuvret L
- type
- Author
- bibliography ids
- nci-bib-0280c5a26b5f96321922b008
- book metadata
- content sha256
- c1336cb1ff34d6308003f27096c4dd53a470c1e6f23a9858da6df0f33dbf7fa7
- document type
- citation
- dois
- 10.1016/j.ejca.2017.03.037
- electronic publication date
- display
- 2017 May 4
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28478340
- immutable id
- pubmed:28478340@c1336cb1ff34d6308003f27096c4dd53a470c1e6f23a9858da6df0f33dbf7fa7
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- Source null
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 119-128
- volume
- 79
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28478340
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 01f6e372c16ff7d86fb5ee7c706034e225e87f8d5776a7cb698e374320460829
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Jul
- precision
- month
- year
- 2017
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Preserved source evidence · Not medical advice